Pre-exposure prophylaxis during the SARS-CoV-2 pandemic: can PrEP prevent COVID-19-related symptoms?

It has been speculated that some drugs can be used against SARS-CoV-2. As for antiretrovirals, the follow-up of pre-exposure prophylaxis (PrEP) users during the coronavirus disease 2019 (COVID-19) outbreak may help to understand the potential protective effect of PrEP against SARS-CoV-2. We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Danilo Euclides, Ferreira, Paulo Roberto Abrão, Mastroianni Kirsztajn, Gianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556904/
https://www.ncbi.nlm.nih.gov/pubmed/32981567
http://dx.doi.org/10.1017/S0950268820002253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556904/
https://www.ncbi.nlm.nih.gov/pubmed/32981567
http://dx.doi.org/10.1017/S0950268820002253

Ejemplares similares